326030 2026-08-27 Biohaven: Sale Of Opakalim Rights To SK Biopharmaceuticals Makes Sense On Many Levels
Edmund Ingham KRX
Sk Biopharmaceuticals Co Ltd
326030
1 article
$5B Market cap · 2026-08-27
326030 2026-08-27 Edmund Ingham 326030 2026-08-27 Edmund Ingham 